Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: AM 1155; BMS 206584; Bonoq; Bonoq Uro; CG 5501; Gatiflo; Gesetz; Tequin; Zymar; Zymaxid

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Kyorin Pharmaceutical
  • Developer Allergan; Kyorin Pharmaceutical; Senju Pharmaceutical
  • Class Antibacterials; Fluoroquinolones; Small molecules
  • Mechanism of Action Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Infectious conjunctivitis
  • Market Withdrawal Acute exacerbations of chronic bronchitis; Bacterial infections; Chlamydial infections; Gonorrhoea; Pneumonia; Respiratory tract infections; Sinusitis; Skin and soft tissue infections; Urinary tract infections
  • Discontinued Anthrax; Otitis media

Most Recent Events

  • 06 Feb 2017 Gatifloxacin is still in under Preregistration for Infectious conjunctivitis in China (Ophthalmic)
  • 19 Jun 2014 Dainippon Sumitomo Pharma is now called Sumitomo Dainippon Pharma
  • 03 Oct 2013 First generic equivalent available in USA for Infectious conjunctivitis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top